The effect of echo contrast agent on Doppler velocity measurements

Ultrasound in Medicine and Biology

Volumn 29, Issue 5, 2003, Pages 765-770

  Yokoyama, Naoyuki ^a   Schwarz, Karl Q ^a,d   Chen, Xucai ^a   Steinmetz, Sherry D ^a   Becher, Harald ^b   Schimpky, Christina ^c   Schlief, Reinhard ^c  

^a UNIVERSITY OF ROCHESTER   (United States)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c BAYER PHARMA AG   (Germany)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Contrast agents; Doppler ultrasound; Echocardiography

Indexed keywords

DOPPLER EFFECT; SPECTRUM ANALYSIS; VIDEO SIGNAL PROCESSING;

POWER SPECTRAL ANALYSIS;

ECHOCARDIOGRAPHY;

SHU 508;

AORTA VALVE DISEASE; ARTICLE; BLOOD FLOW; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER FLOWMETRY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ECHOCARDIOGRAPHY; EVALUATION; FEMALE; FLOW RATE; HUMAN; MALE; MITRAL VALVE DISEASE; PHASE 3 CLINICAL TRIAL; POWER SPECTRUM; PRIORITY JOURNAL; SPECTROSCOPY; VIDEORECORDING;

EID: 0038674446     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-5629(02)00770-6     Document Type: Article

References (17)

1. Basseau F., Grenier N., Trillaud H., Douws C., Saint-Amon A. Doppler frequency shift and time-domain velocity enhancement induced by an ultrasonographic contrast agent. J Ultrasound Med. 19:2000;171-176.
2. Bermejo J., Antoranz J.C., Garcia-Fernandez M.A., Moreno M.M., Delcan J.L. Flow dynamics of stenotic aortic valves assessed by signal processing of Doppler spectrograms. Am J Cardiol. 85:2000;611-617.
3. Forsberg F., Liu J.B., Burns P.N., Merton D.A., Goldberg B.B. Artifacts in ultrasonic contrast agent studies. J Ultrasound Med. 13:1994;357-365.
4. Gutberlet M., Venz S., Zendel W., Hosten N., Felix R. Do ultrasonic contrast agents artificially increase maximum Doppler shift? In vivo study of human common carotid arteries. J Ultrasound Med. 17:1998;97-102.
5. Hundley W.G., Kizilbash A.M., Afridi I., et al. Administration of an IV perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction Comparison with cine magnetic resonance imaging . J Am Coll Cardiol. 32:1998;1426-1432.
6. Kasprzak J.D., Paelinck B., Ten Cate F.J., et al. Comparison of native and contrast-enhanced harmonic echocardiography for visualization of left ventricular endocardial border. Am J Cardiol. 83:1999;211-217.
7. Lambertz H., Schuhmacher U., Tries H.P., Stein T. Improvement of pulmonary venous flow Doppler signal after IV injection of Levovist. J Am Soc Echocardiogr. 10:1997;891-898.
8. Lepper W., Franke A., von Bibra H., et al. Shu 508 A (Levovist)-enhanced Doppler echocardiography improves the assessment of valvular heart disease. Echocardiography. 18:2001;363-372.
9. Melany M.L., Grant E.G., Farooki S., McElroy D., Kimme-Smith C. Effect of US contrast agents on spectral velocities In vitro evaluation . Radiology. 211:1999;427-431.
10. Nakatani S., Imanishi T., Terasawa A., et al. Clinical application of transpulmonary contrast-enhanced Doppler technique in the assessment of severity of aortic stenosis. J Am Coll Cardiol. 20:1992;973-978.
11. Schlief R., Staks T., Mahler M., et al. Successful opacification of the left heart chambers on echocardiographic examination after IV injection of a new saccharide based contrast agent. Echocardiography. 7:1990;61-64.
12. Schwarz K.Q., Becher H., Schimpfky C., et al. Doppler enhancement with SH U 508A in multiple vascular regions. Radiology. 193:1994;195-201.
13. Schwarz K.Q., Bezante G.P., Chen X. When can Doppler be used in place of integrated backscatter as a measure of scattered ultrasound intensity? Ultrasound Med Biol. 21:1995;231-242.
14. Schwarz K.Q., Bezante G.P., Chen X., Mottley J.G., Schlief R. Volumetric arterial flow quantification using echo contrast. An in vitro comparison of three ultrasonic intensity methods Radiofrequency, video and Doppler . Ultrasound Med Biol. 19:1993;447-460.
15. Schwarz K.Q., Bezante G.P., Chen X., Schlief R. Quantitative echo contrast concentration measurement by Doppler sonography. Ultrasound Med Biol. 19:1993;289-297.
16. von Bibra H., Becher H., Firschke C., et al. Enhancement of mitral regurgitation and normal left atrial color Doppler flow signals with peripheral venous injection of a saccharide-based contrast agent. J Am Coll Cardiol. 22:1993;521-528.
17. von Bibra H., Sutherland G., Becher H., Neudert J., Nihoyannopoulos P. Clinical evaluation of left heart Doppler contrast enhancement by a saccharide-based transpulmonary contrast agent. The Levovist Cardiac Working Group. J Am Coll Cardiol. 25:1995;500-508.